Lexicon Pharmaceuticals
LXRX
#7254
Rank
NZ$0.82 B
Marketcap
NZ$2.28
Share price
0.76%
Change (1 day)
81.07%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): NZ-$0.34

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$0.33. In 2024 the company made an earnings per share (EPS) of NZ-$1.10 an increase over its 2023 EPS that were of NZ-$1.38.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.34-69.61%
2024NZ-$1.10-20%
2023NZ-$1.3831.15%
2022NZ-$1.05-0%
2021NZ-$1.0510.91%
2020NZ-$0.95-145.08%
2019NZ$2.11-206.09%
2018NZ-$1.98-5.74%
2017NZ-$2.11-10.95%
2016NZ-$2.362640%
2015NZ-$0.08629-96.34%
2014NZ-$2.35-2.53%
2013NZ-$2.42-9.09%
2012NZ-$2.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
NZ-$132.39 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$74.97-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$10.25 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$4.69-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$29.93-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.93 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.71-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$4.12-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.29 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA